Advertisements

Nystatin STADA

Quick links to important sections

Nystatin STADA

Advertisements
Advertisements

Treatment option: Infection, Oral Cavity

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Nystatin STADA

Property Description
Active ingredient Nystatin (INN)
Form Oral Tablet, Suspension, Cream, Ointment
Pharmacological class Polyene Macrolide Antibiotic / Antifungal
Common use Management of fungal (mycotic) infections
Origin Natural (derived from Streptomyces noursei)

What Type of Medicine is Nystatin STADA and How is it Classified?

Nystatin STADA is a branded medicine containing the active ingredient Nystatin (INN), and is manufactured and distributed by STADA Consumer Health Germany GmbH. It is fundamentally classified as an antifungal medication within the polyene macrolide antibiotic group. The active substance, Nystatin, is a naturally derived small molecule, originally isolated from the bacterium Streptomyces noursei. This classification emphasizes its specific utility against fungal pathogens and distinguishes it from antibacterial agents.


Composition, Forms, and Non-Systemic Purpose

The core composition involves Nystatin delivered alongside an appropriate base/vehicle suitable for its specific dosage form. Nystatin is available in several pharmaceutical preparations, including the oral tablet (often film-coated), suspension (liquid form), cream, and ointment. A key characteristic of Nystatin is its limited gastrointestinal absorption. This ensures its therapeutic effect remains localized or non-systemic, focusing its general purpose on the management of conditions like oral thrush or cutaneous candidiasis through direct application via oral, topical, or mucosal routes.


How Does Nystatin Generally Help Against Fungal Overgrowth?

Nystatin generally helps by directly damaging the structure of the fungal cell, thereby providing effective control over fungal overgrowth. The compound functions by causing cell membrane disruption: it specifically targets ergosterol in the fungal cell wall, creating pores that lead to cell content leakage. This physical interaction results in either a fungistatic (growth-inhibiting) or fungicidal (cell-killing) effect. This mechanism constitutes the drug's essential therapeutic benefit for reducing the proliferation of susceptible yeast-like fungi at the site of infection.

Regulatory References

  1. clinically recognized by the World Health Organization (WHO)
  2. [U.S. Food and Drug Administration (FDA)]
Advertisements

What side effects are possible with Nystatin STADA?

Nystatin STADA is generally well-tolerated, but like all medications, it can cause side effects. Most people experience no side effects or only mild ones.

Common Side Effects

The most commonly reported side effects, especially with oral formulations, are related to the gastrointestinal tract:

  • Gastrointestinal disturbances: Nausea, vomiting, diarrhea, stomach pain, or abdominal discomfort.
  • Oral irritation: Irritation or burning sensation in the mouth (with oral suspension or lozenges).

If you experience persistent or bothersome side effects, consult your doctor or pharmacist.

System Organ Class Frequency Not Specified (Oral) Frequency Not Specified (Topical)
Gastrointestinal Diarrhea, Nausea, Vomiting, Stomach Pain, Abdominal Upset -
Dermatologic/Local Rash Rash, Itching, Burning, Irritation at application site

Serious Side Effects and Safety Information

In very rare cases, Nystatin STADA can cause serious reactions. Seek immediate medical attention if you experience any of the following:

  • Signs of a severe allergic reaction (anaphylaxis): Hives, itching, swelling of the face, lips, tongue, or throat, or difficulty breathing or swallowing.
  • Severe skin reactions: Blistering, peeling, or loosening of the skin (such as Stevens-Johnson syndrome), often accompanied by fever or flu-like symptoms.

Before taking Nystatin, inform your healthcare provider about any known allergies to Nystatin or any of its ingredients. Tell them about all other medications, supplements, and herbal products you are taking. Discuss your medical history, especially if you are pregnant, planning to become pregnant, or breastfeeding.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Nystatin is defined by its limited systemic absorption from the gastrointestinal tract, which is a key characteristic noted in regulatory documents. Oral doses in excess of five million units daily (5,000,000 U/day) have been documented as causing primary manifestations localized to the gastrointestinal system. These documented overdose presentations include nausea, stomach upset, vomiting, and diarrhea.


Official Regulatory Statements on Severity and Action

Regulatory authorities confirm that no reports of serious toxic effects or systemic toxicity have been documented following Nystatin overdosage. Management is structured around this profile, with no specific antidote being known or listed in regulatory labeling. Treatment is therefore limited to symptomatic therapy and general supportive measures.

Urgent medical help must be sought based on the individual's clinical presentation, as mandated by official guidance. Individuals should seek immediate medical attention and contact the Poison Help line if an overdose is suspected. Furthermore, it is required to immediately call emergency services if the person has collapsed, has had a seizure, has trouble breathing, or cannot be awakened. Regulatory advice also suggests checking with a doctor or hospital emergency department regarding overdose in a child.

Advertisements

Therapeutic Uses of Nystatin STADA

What Nystatin STADA Treats: Main Uses and Benefits

Nystatin STADA is commonly used in situations involving distressing symptoms associated with specific conditions. The medicine is applied across domains where short-term symptomatic support and management are appropriate, especially in contexts involving heightened systemic burden. It is relevant in contexts marked by increased discomfort or tension and is used to help address symptom clusters linked to conditions presenting with acute or recurrent episodes.


Understanding the Therapeutic Scope

The medication may be part of supportive management for symptoms related to localized irritative states and systemic imbalances, which often interfere with daily comfort. It is applied in addressing symptom clusters that may become intense or disruptive, and may help patients cope more steadily during phases of increased distress. It is applied for managing symptomatic relief during specific episodes, such as those presenting with or involving a significant symptomatic burden.


Patient Benefits and Focus

The primary benefit is that Nystatin STADA provides support that helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms. It is helpful in scenarios where symptoms escalate temporarily, and may assist with maintaining functional stability. As one might summarize, “Nystatin STADA is generally used to provide short-term assistance for managing noticeable symptom fluctuations.”

Quick Fact: Relief for Symptom Burden Nystatin STADA supports general well-being by assisting with symptomatic relief when discomfort becomes noticeable.

Regulatory References

  1. NIH MedlinePlus Drug Information on Nystatin
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Nystatin STADA? - Official Regulatory Information

The eligibility for Nystatin STADA is strictly defined by regulatory documents, focusing primarily on absolute contraindications and the medicine's non-systemic purpose.


Contraindications and Restrictions

Classification Population/Condition Restriction
Absolute Contraindication Patients with a history of hypersensitivity (allergy) to Nystatin or any of the specific formulation's inactive components.
Use Restriction Must not be used for the treatment of systemic mycoses (deep or widespread internal fungal infections), as Nystatin is negligibly absorbed into the bloodstream.

Age-Group and Special Population Eligibility

The medicine is generally established for use across all age groups, but with formulation-specific guidance.

  • Adults, Adolescents, and Older Adults are eligible for use without specific age-based dosage adjustments or precautions.
  • Infants and Children are eligible for use, especially with oral suspension formulations. Specific oral dosage forms, like tablets or lozenges, may be restricted to children aged five years and older for safety reasons.
  • Pregnancy and Lactation: Use during pregnancy is advised only if clearly needed, and caution is exercised when administering to a nursing mother, as regulatory data on excretion into human milk is not fully established.

No specific restrictions for use in patients with renal or hepatic impairment are generally required due to the medicine's limited absorption.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Nystatin STADA's official interaction profile is defined by its negligible systemic absorption when taken orally, which limits the potential for systemic drug-drug interactions, such as those involving liver metabolism.

Documented Pharmacodynamic and Local Interactions

The primary documented interactions involve local effects or antagonism with co-administered products:

  • Antifungal Efficacy Reduction: Co-administration with certain other antifungals, such as Clotrimasole, may lower the activity of the co-administered medicine.
  • Live Yeast Supplements: Nystatin may decrease the therapeutic effect of live yeast probiotic supplements like Saccharomyces boulardii.
  • Topical Biological Products: The co-administration of Nystatin with allogeneic cultured keratinocytes/fibroblasts (topical biological products) requires formal restrictions. A suitable wash-out period must be observed following exposure to Nystatin to prevent product degradation.

Population-Specific Interaction Consideration

Under normal conditions, Nystatin plasma concentrations are insignificant. However, regulatory information specifically notes that in patients with renal insufficiency, significant plasma concentrations of nystatin may occasionally occur. This population-specific consideration regarding the drug’s potential systemic exposure warrants regulatory caution.

Advertisements

Mechanism of Action

Selective Fungal Membrane Destabilization

The primary mechanism involves the direct binding of Nystatin to ergosterol, a sterol molecule that is essential for the structural integrity of the fungal cell membrane but is absent in human cells. This highly specific binding initiates the intercalation of the Nystatin molecule into the lipid layer, which disrupts the selective barrier function of the fungal cell.


Abolition of Cellular Homeostasis and Ionic Gradients

The insertion of Nystatin leads to the formation of large, destructive transmembrane pores or channels. These pores destroy the cell's osmotic and electrochemical balance, causing the uncontrolled leakage of vital intracellular contents, most notably potassium ions (K^+). This loss of key molecules results in the functional destruction (lysis) of the pathogen, delivering a concentration-dependent fungicidal or fungistatic effect resulting from the destruction or growth arrest of the fungal organism.


️ Mechanism Specificity and Constraint

The mechanism is constrained by its lack of affinity for cholesterol, the sterol in human membranes, causing the destructive action to be restricted to the fungal target. This inherent target selectivity contributes to the mechanism remaining localized to the site of application.

Advertisements

Dosage and Administration Information

Administration Scope

The general principles of using Nystatin are highly dependent on the targeted site of infection, necessitating either the oral route (for tablets and suspension) or the topical route (for creams and powders). A core constraint of its use is that the drug is not intended for the treatment of systemic mycoses, as its absorption from the gastrointestinal tract is negligible.

Property Usage Pattern (Adults)
Standard Dose Oral tablets are commonly dosed between 500,000 to 1,000,000 units per administration. Oral suspension is often dosed between 400,000 to 600,000 units per dose.
Frequency Oral tablets are typically administered three times daily (TID). Oral suspension is administered four times daily (QID), with doses evenly spaced.

Special Procedural Conditions

Administration of the oral suspension requires specific techniques to ensure proper localized effect. The bottle must be shaken well prior to each use to ensure uniform concentration. The measured dose is officially directed to be retained in the mouth as long as possible before swallowing, often divided between the sides of the mouth to maximize mucosal contact.

For pediatric patients, specific unit doses, such as 100,000 to 200,000 units, are prescribed for infants, and feeding should be avoided for 5 to 10 minutes after suspension use.


Course Duration and Protocol

The usage protocol dictates that treatment is continued for a minimum of 48 hours after symptoms have clinically resolved. This requirement establishes a duration pattern that is independent of the immediate disappearance of symptoms, defining the proper time course for the therapy.

Advertisements

Recent Clinical Evidence

Nystatin STADA: Recent Clinical Evidence

Research on Nystatin, the active ingredient in Nystatin STADA, primarily involves Randomized Controlled Trials (RCTs) and Systematic Reviews for two main areas: localized fungal infections like oral candidiasis (oral thrush) and fungal presence in the gastrointestinal tract. For localized infections, studies monitored specific outcomes related to physical discomfort and the mycological outcome rate. Research examining its role in the gut, often for prophylaxis in high-risk patients like those who are severely immunocompromised, explored outcomes related to fungal colonization levels and invasive fungal infection.

Study populations have been diverse, including infants and neonates, children, and older adults. Nystatin was also evaluated in specific trials involving immunocompromised individuals to assess symptom patterns in these vulnerable populations. However, the follow-up durations were limited in most trials, typically focusing only on the acute treatment phase. This means that long-term effects are not fully established, and there is limited information on sustained durability of observed changes or recurrence rates over extended periods.

Scientific literature indicates areas where the evidence base has not yet provided definitive conclusions. Evidence quality varies across studies, and findings were mixed in head-to-head comparisons where research examined newer, systemically absorbed antifungal drugs. The data are still emerging concerning its comparative use in preventing systemic infections. The results apply only to the populations studied, and current evidence has comparative evidence lacking against newer therapies. Findings describe group patterns, not personal outcomes.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Nystatin STADA (FAQ)


Q: How quickly should I expect to see results from Nystatin STADA?

A: Studies indicate that initial symptom relief for conditions like oral thrush is often observed within 24 to 72 hours of starting treatment. Official guidance emphasizes the need to complete the full prescribed course to ensure the fungal infection is fully addressed, even if symptoms clear up quickly.


Q: What happens if I stop using Nystatin STADA too early?

A: Official protocols state that treatment should continue for a minimum of 48 hours after your symptoms have completely resolved. Stopping use prematurely is associated with the risk of recurrence, as the fungal infection may not be fully eliminated.


Q: Can people with diabetes use Nystatin STADA?

A: Some oral suspension forms of Nystatin contain sucrose (sugar) as an inactive ingredient. While the medicine is generally non-systemic, regulatory information suggests that individuals managing conditions like diabetes or who have specific sugar intolerances should review the product’s list of inactive ingredients.


Q: Can Nystatin STADA be used while breastfeeding?

A: Regulatory information indicates it is not known whether Nystatin passes into human breast milk. Official guidance advises that caution be used when this medicine is prescribed for a nursing mother.


Q: What kind of research evidence supports the use of Nystatin STADA for oral candida?

A: Scientific literature confirms that Nystatin is indicated for use in treating oral candidiasis (oral thrush). Published research, including systematic reviews, has observed mycological cure rates ranging between 14% and 77% across different studies and populations.


Q: Do any official documents describe Nystatin STADA as having low absorption?

A: Yes, official product labeling specifically states that the gastrointestinal absorption of Nystatin is insignificant (negligible). This confirms that very little of the medicine enters the bloodstream when used orally.


Q: Does Nystatin STADA treat bacterial infections too?

A: Nystatin is classified as an antifungal and only works against yeast and fungal infections. Official documents confirm it exhibits no appreciable activity against other types of microorganisms, such as bacteria, protozoa, or viruses.


Q: Is Nystatin STADA the same as Nystatin powder or cream?

A: Nystatin is the single active ingredient found in all Nystatin products, whether they are oral suspensions, powders, or creams. The STADA name refers to the specific brand or manufacturer producing that medicine formulation.


Q: What is the difference between Nystatin STADA and Fluconazole?

A: The primary difference lies in how the body handles the medicine. Nystatin is poorly absorbed and works locally at the site of infection. Fluconazole, an azole antifungal, is absorbed systemically, meaning it is distributed throughout the body via the bloodstream.


Q: Are there any known side effects on the liver from Nystatin STADA?

A: Due to Nystatin’s negligible systemic absorption, it is considered unlikely to cause clinically apparent injury to the liver, as the substance primarily remains localized to the area of application.


Q: Can Nystatin STADA affect the taste in my mouth?

A: Yes, adverse event reviews have indicated that a change in the sense of taste has been reported by some users. This side effect can sometimes be described as a metallic taste.


Q: Does Nystatin STADA interact with any common herbal supplements?

A: There is generally not enough formal information to confirm that all herbal remedies and supplements are safe to take alongside Nystatin. Official drug testing typically focuses on prescription drugs and does not cover every possible herbal or complementary medicine.


Q: Is it okay to drink alcohol while using Nystatin STADA?

A: Some oral suspension formulations list a small amount of alcohol (1% or less by volume) as an inactive ingredient. Official regulatory documents do not provide a specific general warning or prohibition against consuming alcoholic beverages while using Nystatin.


Q: Does Nystatin STADA contain sugar or sweeteners?

A: Some oral suspension forms of Nystatin contain sucrose (sugar) as one of the inactive ingredients. Labeling advises consulting the specific product information for a full list of inactive components.


Q: Is Nystatin STADA gluten-free or lactose-free?

A: The composition varies based on the formulation. Some Nystatin suspension products are officially indicated as free of added gluten. For specific dietary requirements regarding gluten or lactose, it is advised to check the inactive ingredient list of the specific formulation being used.


Q: Is Nystatin STADA available without a prescription in some places?

A: In the United States, FDA-labeled oral Nystatin products are identified as prescription-only drugs and are labeled as 'Rx Only'. Availability and prescription requirements can vary by country.


Q: Has Nystatin STADA been studied in children?

A: Yes, official literature confirms that Nystatin has been studied in pediatric populations, including infants and neonates. The drug is officially labeled for use in children.


Q: Is there a maximum time someone can use Nystatin STADA?

A: Official labeling specifies a minimum duration for use (until symptoms are resolved plus at least 48 hours). Regulatory guidance indicates that individuals should seek advice from a healthcare provider if symptoms do not improve after 14 days of treatment.


Q: Is Nystatin STADA absorbed into the bloodstream after use?

A: According to official pharmacological information, the absorption of Nystatin from the gastrointestinal tract is described as insignificant or negligible. This means that only very minimal amounts, if any, enter the bloodstream.


Q: Can Nystatin STADA affect the results of any medical tests?

A: Yes, official interaction summaries note that Nystatin is known to interact with the coccidioidin skin test. Official recommendations state that a healthcare provider should be informed about all medicines being used prior to medical testing.


Q: Is Nystatin STADA effective against all types of fungus?

A: Nystatin is effective against a wide range of yeasts and yeast-like fungi, such as Candida. However, product labeling does not claim efficacy against all possible types of fungi.


Q: Does Nystatin STADA lose effectiveness over time?

A: To ensure the medicine maintains its stability and effectiveness, official storage instructions advise against using Nystatin after the expiry date shown on the label. The product should be stored according to the labeled temperature and protection requirements.


Q: How is the active ingredient in Nystatin STADA obtained?

A: The active ingredient, Nystatin, is a naturally derived substance. It is classified as a polyene antibiotic and is obtained from the bacterium Streptomyces noursei.


Q: Is a patch of redness in the mouth a reason to stop Nystatin STADA?

A: Official precautions advise that if symptoms of sensitization or irritation are reported during use, treatment should be discontinued. Individuals are advised to contact a healthcare professional to review symptoms that may be bothersome.


Q: Can Nystatin STADA interact with medications for high blood pressure?

A: Because Nystatin has insignificant systemic absorption, it is described as having limited potential for systemic drug-drug interactions. This typically includes common systemic medications like those prescribed for high blood pressure.


Q: Why is proper hygiene mentioned in relation to Nystatin STADA use?

A: General patient information often stresses the importance of hygiene to prevent reinfection, as fungal infections thrive in moist conditions. For example, using freshly washed clothing or proper cleaning of oral devices is sometimes advised to support the overall treatment.

Advertisements

How should Nystatin STADA be stored and disposed of?

How to Store and Dispose of Nystatin STADA: Official Regulatory Information

Storage Requirements

Nystatin STADA must be stored according to the official labeling to maintain stability. The medicine must be kept out of the sight and reach of children.

Storage Condition Requirement
Temperature Store at Controlled Room Temperature, typically below 25 C.
Protection Do not freeze the suspension. Keep in the original container, tightly closed, and away from excess heat and moisture.
Stability Do not use after the expiry date shown on the label.

Disposal Instructions

Dispose of unused or expired Nystatin STADA according to local guidelines for pharmaceutical waste. Do not throw away this medicine via wastewater or household waste, as these measures help protect the environment. Consult a pharmacist for proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nystatin STADA found in:

A-Z Index: